Barbara A. Hendrickson

机构：University of Chicago · ORCID：0000-0002-8722-3455

发表论文 67 篇 · 总被引 2819 次 · h-index 22

代表论文

Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial (2021 · The Lancet · 被引 405)
Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme (2020 · Annals of the Rheumatic Diseases · 被引 238)
Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies (2022 · Journal of Allergy and Clinical Immunology · 被引 68)
Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting (2019 · RMD Open · 被引 28)
Aggregate Safety Assessment Planning for the Drug Development Life-Cycle (2021 · Therapeutic Innovation & Regulatory Science · 被引 20)
A Framework for Safety Evaluation Throughout the Product Development Life-Cycle (2019 · Therapeutic Innovation & Regulatory Science · 被引 16)